Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillator Study

Keyphrases

• Implantable Defibrillator 100%
• Implantable Cardioverter-defibrillator Therapy 100%
• Patient Identification 100%
• Amiodarone 25%
• High Risk 16%
• Risk of Death 16%
• Ventricular Arrhythmia 16%
• Left Ventricular Ejection Fraction 16%
• Risk Factors 8%
• Treatment Effect 8%
• Clinical High Risk 8%
• Risk Score 8%
• Functional Status 8%
• Relative Risk Reduction 8%
• Ventricular Tachycardia/ventricular Fibrillation 8%
• Medical Therapy 8%
• Ventricular Function 8%
• Advanced Age 8%
• Mortality Reduction 8%
• NYHA Class 8%
• Multivariate Cox Analysis 8%

Medicine and Dentistry

• Implantable Automatic Defibrillator 100%
• Defibrillator 100%
• Ventricular Tachycardia 27%
• Amiodarone 27%
• New York Heart Association Class 18%
• Heart Left Ventricle Ejection Fraction 18%
• Proportional Hazards Model 9%
• Combination Therapy 9%
• Treatment Effect 9%
• Functional Status 9%
• Relative Risk Reduction 9%
• Age 9%
• Ventricular Fibrillation 9%
• Heart Ventricle Function 9%